Literature DB >> 30281932

Genetic Engineering of Human Pluripotent Stem Cells Using PiggyBac Transposon System.

Mi Ae Park1, Ho Sun Jung1, Igor Slukvin1,2,3.   

Abstract

Human pluripotent stem cells (hPSCs) emerged as an important tool to investigate human development and disease. These studies often require genetically engineering hPSCs to stably express a transgene, which remains functional in various hPSC progeny. PiggyBac transposon is a highly effective and technically simple vector system with large cargo space available for permanent gene delivery. This unit describes the use of PiggyBac transposons to genetically engineer hPSCs to introduce conditionally expressed transgene or reporter to effectively monitor gene expression during differentiation. Both methods enable robust generation of stable hPSC lines within 1 month.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  PiggyBac transposon system; genetic engineering; human pluripotent stem cells

Mesh:

Substances:

Year:  2018        PMID: 30281932      PMCID: PMC6212322          DOI: 10.1002/cpsc.63

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  22 in total

1.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

2.  Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells.

Authors:  Xin Huang; Hongfeng Guo; Syam Tammana; Yong-Chul Jung; Emil Mellgren; Preetinder Bassi; Qing Cao; Zheng Jin Tu; Yeong C Kim; Stephen C Ekker; Xiaolin Wu; San Ming Wang; Xianzheng Zhou
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

3.  The hESC line Envy expresses high levels of GFP in all differentiated progeny.

Authors:  Magdaline Costa; Mirella Dottori; Elizabeth Ng; Susan M Hawes; Koula Sourris; Pegah Jamshidi; Martin F Pera; Andrew G Elefanty; Edouard G Stanley
Journal:  Nat Methods       Date:  2005-03-23       Impact factor: 28.547

4.  Chromosomal transposition of PiggyBac in mouse embryonic stem cells.

Authors:  Wei Wang; Chengyi Lin; Dong Lu; Zeming Ning; Tony Cox; David Melvin; Xiaozhong Wang; Allan Bradley; Pentao Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

5.  Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.

Authors:  Sheng Ding; Xiaohui Wu; Gang Li; Min Han; Yuan Zhuang; Tian Xu
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

Review 6.  piggyBac-ing models and new therapeutic strategies.

Authors:  Lauren E Woodard; Matthew H Wilson
Journal:  Trends Biotechnol       Date:  2015-07-23       Impact factor: 19.536

7.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Time-lapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation.

Authors:  Ivana Barbaric; Veronica Biga; Paul J Gokhale; Mark Jones; Dylan Stavish; Adam Glen; Daniel Coca; Peter W Andrews
Journal:  Stem Cell Reports       Date:  2014-06-12       Impact factor: 7.765

9.  A Hyperactive Transposase Promotes Persistent Gene Transfer of a piggyBac DNA Transposon.

Authors:  Erin R Burnight; Janice M Staber; Pavel Korsakov; Xianghong Li; Benjamin T Brett; Todd E Scheetz; Nancy L Craig; Paul B McCray
Journal:  Mol Ther Nucleic Acids       Date:  2012-10-16       Impact factor: 10.183

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  7 in total

1.  Generation of T cells from Human and Nonhuman Primate Pluripotent Stem Cells.

Authors:  Akhilesh Kumar; Saritha S D'Souza; Gene Uenishi; Mi Ae Park; Jeong Hee Lee; Igor I Slukvin
Journal:  Bio Protoc       Date:  2020-07-05

2.  SOX17 integrates HOXA and arterial programs in hemogenic endothelium to drive definitive lympho-myeloid hematopoiesis.

Authors:  Ho Sun Jung; Gene Uenishi; Mi Ae Park; Peng Liu; Kran Suknuntha; Matthew Raymond; Yoon Jung Choi; James A Thomson; Irene M Ong; Igor I Slukvin
Journal:  Cell Rep       Date:  2021-02-16       Impact factor: 9.423

3.  Improvement on the genetic engineering of an invasive agricultural pest insect, the cherry vinegar fly, Drosophila suzukii.

Authors:  Hassan M M Ahmed; Fabienne Heese; Ernst A Wimmer
Journal:  BMC Genet       Date:  2020-12-18       Impact factor: 2.797

4.  Protocol for inducible piggyBac transposon system for efficient gene overexpression in human pluripotent stem cells.

Authors:  Jiwen Yang; Minjie Hu; Yongyu Wang
Journal:  STAR Protoc       Date:  2022-04-13

5.  Targeted RNA N6 -Methyladenosine Demethylation Controls Cell Fate Transition in Human Pluripotent Stem Cells.

Authors:  Xuena Chen; Qingquan Zhao; Yu-Li Zhao; Guo-Shi Chai; Weisheng Cheng; Zhiju Zhao; Jia Wang; Guan-Zheng Luo; Nan Cao
Journal:  Adv Sci (Weinh)       Date:  2021-03-18       Impact factor: 16.806

6.  Structural basis of seamless excision and specific targeting by piggyBac transposase.

Authors:  Qiujia Chen; Wentian Luo; Ruth Ann Veach; Alison B Hickman; Matthew H Wilson; Fred Dyda
Journal:  Nat Commun       Date:  2020-07-10       Impact factor: 14.919

7.  An episomal DNA vector platform for the persistent genetic modification of pluripotent stem cells and their differentiated progeny.

Authors:  Alicia Roig-Merino; Manuela Urban; Matthias Bozza; Julia D Peterson; Louise Bullen; Marleen Büchler-Schäff; Sina Stäble; Franciscus van der Hoeven; Karin Müller-Decker; Tristan R McKay; Michael D Milsom; Richard P Harbottle
Journal:  Stem Cell Reports       Date:  2021-12-22       Impact factor: 7.765

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.